Latest Financial Performance News

Webjet Group navigated a challenging FY26 with flat OTA revenue and strong EBITDA margins, while its Cars & Motorhomes segment began turning around. The company withheld FY27 earnings guidance, citing ongoing macro uncertainty but noted improved recent trading.

ImpediMed reported a 15% revenue increase to $14.6 million in FY26, broadened reimbursement coverage for its SOZO platform to 95% of the US population, and launched new applications in heart health and weight management.

Redox Limited posted a strong FY26 with record revenue of $1.33 billion, a 19.2% jump in statutory net profit, and a 4% dividend increase, while announcing a board leadership transition.

Credit Clear Limited posted a 28% rise in FY26 revenue to $60 million, boosted by UK acquisitions and organic growth, while defending legal action by the ACCC.

State Street's suite of Australian equity ETFs delivered solid operating profits and net asset growth for the year ended 30 June 2026, with most funds closely tracking or outperforming their benchmarks.

Aerometrex delivered a landmark FY26 with operating revenue up 12.3% to $26.84 million and EBITDA more than doubling to $7.68 million, driven by a 27.2% jump in MetroMap subscription revenue and a 37.8% rise in Annual Contract Value.

Horizon Oil Limited delivered record FY26 production of 2.15 million barrels of oil equivalent and expanded its reserves by 51% to 13.6 million boe, driven by strategic acquisitions and disciplined capital management.

Genesis Energy posted a robust FY26 with Normalised EBITDAF up 11% to $522m, driven by margin growth and strategic investments in renewables and battery storage. A $400m equity raise bolstered its balance sheet as it accelerates New Zealand’s energy transition.

Precinct Properties delivered steady FY26 results marked by record leasing activity, expanded capital partnerships, and a maintained dividend guidance, while advancing key development projects including the Downtown Car Park.

Associate Global Partners (ASX:APL) reported a 20% rise in funds under management to $1.672 billion for FY2026, driven by strong inflows and new partnerships with Muzinich and ARK Invest.

Lynas Rare Earths delivered a record A$977.9 million revenue and A$222.4 million net profit in FY26, underpinned by strong rare earth production, strategic supply agreements, and a 10-year Malaysian licence renewal.

ParagonCare’s FY26 results show modest revenue and underlying earnings growth, overshadowed by a large credit loss provision related to the Infinity Pharmacy Group debt.